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Abstract
Background: Live kidney transplantation (LKT) is underutilized, particularly among ethnic/racial minorities. The
effectiveness of culturally sensitive educational and behavioral interventions to encourage patients’ early, shared
(with family and health care providers) and informed consideration of LKT and ameliorate disparities in
consideration of LKT is unknown.
Methods/Design: We report the protocol of the Talking About Live Kidney Donation (TALK) Study, a two-phase
study utilizing qualitative and quantitative research methods to design and test culturally sensitive interventions to
improve patients’ shared and informed consideration of LKT. Study Phase 1 involved the evidence-based
development of culturally sensitive written and audiovisual educational materials as well as a social worker
intervention to encourage patients’ engagement in shared and informed consideration of LKT. In Study Phase 2,
we are currently conducting a randomized controlled trial in which participants with progressing chronic kidney
disease receive: 1) usual care by their nephrologists, 2) usual care plus the educational materials, or 3) usual care
plus the educational materials and the social worker intervention. The primary outcome of the randomized
controlled trial will include patients’ self-reported rates of consideration of LKT (including family discussions of LKT,
patient-physician discussions of LKT, and identification of an LKT donor). We will also assess differences in rates of
consideration of LKT among African Americans and non-African Americans.
Discussion: The TALK Study rigorously developed and is currently testing the effectiveness of culturally sensitive
interventions to improve patients’ and families’ consideration of LKT. Results from TALK will provide needed
evidence on ways to enhance consideration of this optimal treatment for patients with end stage renal disease.
Trial Registration: ClinicalTrials.gov number, NCT00932334
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Background
Living related kidney transplantation (LKT) represents
an optimal strategy for the treatment of patients with
end stage renal disease (ESRD), offering recipients sub-
stantially improved length and quality of life when com-
pared to patients receiving dialysis [1]. However,
evidence suggests LKT has been consistently underuti-
lized, particularly among ethnic/racial minorities, who
have been demonstrated to be up to 50% less likely than
non-minorities to receive LKT [2]. Underutilization of
LKT has been attributed, in part, to potential recipients’
lack of knowledge about LKT [3,4], denial about the
need to consider LKT [5], difficulties approaching and
identifying donors [6], potential recipients’ fears regard-
ing the health of potential donors [7], mistrust of health
care and concerns about surgery [8], and suboptimal
discussions about LKT between potential recipients,
their families, and health care providers [9].
Little is known about effective strategies for improving
patients’ and families’ early consideration of LKT. Con-
sideration of LKT prior to patients’ development of
ESRD could provide time for both recipients and poten-
tial donors (often family members) to fully consider the
risks and benefits of LKT, enhancing the probability
that their decisions regarding pursuit of LKT align with
their personal values. Early consideration of LKT may
be particularly important in facilitating and preparing
for pre-emptive (before the start of dialysis) LKT–
which is associated with the most superior clinical out-
comes [10]. Despite this, studies show most patients,
particularly ethnic/racial minorities, do not consider
LKT as a treatment option until after they have initiated
hemodialysis, and that family and physician discussions
about LKT are often suboptimal even when patients
report they desire LKT as a treatment [3,9].
Patients who have not yet progressed to ESRD may
have unique barriers to considering LKT, including their
lack of awareness of the severity of their kidney disease
[11] and low perceived susceptibility to kidney disease
progression and ESRD [12]. Evidence suggests patients
with progressing kidney disease and their families, parti-
cularly ethnic/racial minorities, may also have avoidant
coping strategies which hinder their collaborative deci-
sion making [5]. Patients may also feel they have inade-
quate skills to initiate discussions about LKT with their
families and health care providers, further limiting
opportunities for early consideration of LKT [13]. Stu-
dies assessing the effectiveness of culturally sensitive
approaches to improve patients’ early shared, and
informed consideration of LKT are needed.
We describe the protocol for a two phase study in
which we 1) developed culturally sensitive educational
and behavioral interventions to improve patients’ early,
shared, and informed consideration of LKT and 2) are
currently testing the effectiveness of these interventions
to improve patients’ consideration of LKT in a rando-
mized controlled trial.
Methods/Design
Study Design Summary
The Talking about Live Kidney Donation (TALK) study
is a two-phase study to design and test the effectiveness
of culturally sensitive behavioral and educational inter-
ventions on patients’ early, shared, and informed consid-
eration of LKT. In Phase 1, we developed culturally
sensitive interventions and we developed and piloted
data collection tools. In Phase 2, we are currently con-
ducting a randomized controlled trial to assess the effec-
tiveness of interventions to improve patients’ shared and
informed consideration of LKT. The Johns Hopkins
School of Medicine Institutional Review Board has
approved all study procedures.
Phase 1: Development of Culturally Sensitive Educational
and Behavioral Interventions
Interventions were developed on the basis of evidence
obtained through (1) a review of published scientific lit-
erature informing barriers to patients’ pursuit of LKT
among minorities and non-minorities as well as a review
of lay publications (brochures, pamphlets) produced by
patient advocacy organizations and government agencies
to educate patients on LKT [14-16], and (2) primary
data collection from qualitative group interviews of Afri-
can American and non-African American patients and
families with varying levels of experience regarding pur-
suit of LKT. Full details regarding the conduct of group
interviews are published elsewhere [13].
Development of Educational Booklet and Video
The educational booklet and video were developed by a
team of experts, including a transplant nephrologist, a
transplant surgeon, a transplant social worker, a general
internist, a behavioral psychologist, experts in develop-
ing interventions to address health disparities, experts in
creating health literacy sensitive educational materials,
and patient advocates from the National Kidney Foun-
dation of Maryland. Educational materials provide com-
plimentary information to encourage patient and
families’ shared and informed consideration of LKT,
including: 1) information about eligibility for LKT, 2)
the clinical evaluation required for LKT, 3) the donor
selection process, 4) surgical procedures for transplanta-
tion and donation, 5), and concerns brought forth about
these factors (e.g. safety of procedures, concerns about
recovery) identified through the structured group inter-
views [13].
Both the booklet and the video are designed to be
reviewed by patients and their families. The booklet is
designed to be read at a fourth to sixth grade reading
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level and to be sensitive to persons with limited health
literacy [17]. It also provides example ‘model conversa-
tions’ which patients and/or family members might use
to initiate LKT discussions as well as strategies for
handling difficult issues (e.g., concerns about pressuring
donors during discussions about LKT (for patients) or
methods for approaching potential recipients in need of
LKT (for family members)), a glossary of commonly
used medical terms related to LKT as well as informa-
tion about publicly available resources for obtaining
further information about LKT. The video features testi-
monials from African American and non-African Amer-
icans patients and families about their experiences with
considering LKT (including deliberations about donation
and the impact of LKT on their families) and also fea-
tures physicians and social workers describing factors (e.
g. such as the need for social support and regular medi-
cal follow up) that patients and families should consider
with regard to LKT. The video also addresses African
Americans’ potential mistrust of the transplant process.
The video and booklet were both screened by African
American and non-African American patients and
families prior to final production and their input was
incorporated into the final interventions.
Development of behavioral social worker intervention and
intervention protocol
We have developed a family-based social worker inter-
vention founded on well-established Social Construc-
tion-based Family Problem Solving Theory, [18-20] to
address barriers to patients consideration of LKT. The
intervention is based on five key principles derived from
Family Problem Solving Theory which center on the
value of the health care practitioner (social worker) to
facilitate the resolution of difficult issues or decisions by
encouragement of mutual family discourse and by assist-
ing families’ develop strategies for problem management.
(Table 1) Additional core principles underlying the
intervention include the discussion of all forms of renal
replacement therapy as reasonable treatment options
and the avoidance of coercion of potential living donors
toward donation in all discussions.
During the intervention, a social worker engages
potential LKT recipients in one-on-one meetings and, if
potential recipients desire, also engages potential recipi-
ents and their families in a follow-up family meeting. In
one-on-one meetings with potential recipients, the social
worker probes to assess specific factors potential recipi-
ents perceive inhibit them from progressing through
behaviors necessary to achieve LKT (including perceived
lack of knowledge regarding LKT, fears regarding the
procedure and life after LKT, concerns regarding the
health and well-being of potential family donors, and
resources necessary for shared decision-making regard-
ing patient’s kidney failure). In follow-up meetings with
families, the social worker probes to assess specific con-
cerns or barriers family members perceive might inhibit
them from pursuing LKT (including strained relation-
ships, financial concerns, and logistical issues). The
social worker also probes to assess the extent to which
previous family discussions about patients’ CKD have
occurred, the results of those discussions, whether
families have discussed living LKT with patients’ physi-
cians, and barriers families perceive for an open discus-
sion about living kidney donation/transplantation with
patients’ physicians. The social worker’s assessments of
factors primarily affecting potential recipients’ decision-
making at the time of the intervention will guide their
development of individualized culturally sensitive inter-
vention plans based on the perceived needs of the
potential recipient. Thus, goals of patient and family
meetings will be based on which factors are felt to be
most prominent for each individual potential recipient
and their family. The social worker is also available to
patients and families for the provision of information
regarding LKT as well as for limited facilitation of
further family communication. Social workers employed
in the intervention have been trained in techniques for
brief individual/family therapy by a behavioral psycholo-
gist with experience with problem solving interventions.
Social workers have also been trained in effective cross-
cultural communication and negotiation utilizing the
model for education in cultural competence developed
by the American Association of Medical Colleges [21].
Table 1 Underlying principles of social worker brief
counseling sessions for patients and family members
Core Tenets Underlying Conduct of Family Problem Solving
Intervention (General)
• The act of participating in mutual discourse with others enables
individuals to create meaning and purpose from their life experiences.
• Problem-solving conversations allow individuals to be involved in a
mutual search for and creation of new solutions to their problems.
• A client system is composed of those who are joined for the purpose
of dialogue around problems or issues of mutual concern. The clinician
must enter into dialogue with the family to become part of the
collective view needed to assist in creating new solutions with the
family.
• The ways in which family members communicate with one another
define their collective view about a problem.
• The role of the clinician is to create space for and facilitate
conversations through which the family can find new meanings and
mutually acceptable solutions for existing health problems.
Principles Specific to Family Problem Solving for LKT
• Discussion and education regarding all treatment options available to
patients (including dialysis, deceased kidney transplantation, living
related kidney transplantation, and living unrelated kidney
transplantation) will occur.
• Encouragement of truly shared decision-making and avoidance of
coercion of family members toward donation is a core component of
discussions.
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Phase 2: Conduct of Randomized Controlled Trial
We are currently conducting a randomized controlled
trial to assess the incremental effectiveness of educa-
tional materials and the social worker intervention on
improving patients’ and families’ engagement in shared
and informed consideration of LKT.
Target Population and Eligibility Criteria
We are targeting patients with advanced, progressive
chronic kidney disease who have not yet initiated dialy-
sis therapy and their family members for participation.
Patients are recruited from five academically affiliated
and community-based nephrology practices in the Balti-
more, MD metropolitan region, which we have selected
to provide an ethnically and socioeconomically diverse
population of participants. To identify potential partici-
pants with kidney disease, we ask nephrologists from
participating practices to identify from their patients
with National Kidney Foundation Kidney Disease Out-
comes Quality Initiative (KDOQI) Stages 4 or 5 (not
dialysis dependent) CKD (glomerular filtration rates ≤
30 ml/min/1.73 m2), those whom the physicians believe
are potentially eligible for kidney transplantation based
on the following criteria: age 18 to 70; no evidence of
cancer within 2 years prior to recruitment date; no evi-
dence of stage IV congestive heart failure; no evidence
of end-stage liver disease; no evidence of unstable cor-
onary artery disease; no evidence of pulmonary hyper-
tension; no evidence of severe peripheral vascular
disease; no history of HIV; no chronic (debilitating)
infections; and no prior kidney transplant.
Recruitment of patient participants
We recruit patient participants via both active and pas-
sive strategies. We recruit participants passively via bro-
chures and recruitment flyers (encouraging potential
participants’ self referral) placed in practice waiting
rooms and examination rooms. The brochures provide a
description of the study goals, participant eligibility cri-
teria, and the contact phone number and e-mail for the
coordinating center. We actively identify potentially eli-
gible participants by screening nephrology practices’
administrative (i.e. billing codes, Table 2) and clinical
records (i.e. using a modified estimation equation
derived from the Modification of Diet in Renal Disease
Study [22], which incorporates serum creatinine, patient,
age, race, and gender to estimate glomerular filtration
rate) on all patients seen at the clinical practice sites
over the previous 12 months to identify persons with
CKD stages 4 or 5 (non-dialysis dependent). We have
obtained a HIPAA waiver to screen medical records to
confirm potential eligibility among potential participants
identified through billing codes. Once we have identified
potentially eligible participants through screening, we
forward their names to their nephrologists for confirma-
tion of their potential eligibility. We mail all potentially
eligible participants a letter from their physician group
advising them that they are eligible to participate in the
study along with a letter from the study principal inves-
tigator with a brief summary of the study eligibility cri-
teria, objectives, what they would be asked to do as a
study participant, and information on how to contact
the study recruiters by telephone. Letters include self-
addressed stamped envelopes with standard refusal post-
cards allowing potential participants to refuse participa-
tion. We provide potentially eligible participants
fourteen (14) days to refuse either by mail or phone.
We do not contact potentially eligible persons who
refuse. If the study coordinating center does not hear
from the participant, trained recruiters attempt to con-
tact potential participants by telephone and assess their
willingness to participate in the study using a standar-
dized telephone script and oral consent process. Upon
confirmation of their eligibility to participate, we ran-
domly assign participants into intervention groups.
Recruitment of family member participants
At the time of their one (1) month follow up telephone
assessment, we ask all patient participants (regardless of
intervention assignment) to identify a family member
they feel they would involve in an important medical
consideration, such as the consideration to pursue LKT
to participate in a telephone questionnaire. We offer
patient participants two options for contacting family
members: 1) patient participants may contact family
members or friends themselves and invite them to con-
tact the study coordinating center, or 2) patient partici-
pants may let family members or friends know that they
have provided their family members’ contact informa-
tion to the study and that the coordinating center will
contact the family member. We recruit family members
using a prepared telephone script and oral consent
process.
For patient participants randomized to receive the
social worker intervention (see intervention groups
below), we ask participants to invite family members to
a follow-up visit with the social worker. Prior to
Table 2 Administrative codes used to identify potential
participants with stages 4 and 5(non-dialysis dependent)
CKD for the TALK study
Condition ICD-9 Code
Diabetic nephropathy 250.4, 250.40, 250.41, 250.42,
250.43
Hypertensive nephropathy 403.00-403.91
Hypertensive heart and kidney disease 404.00-404.93
Nephrotic syndrome 581
Chronic kidney disease 585, 585.4, 585.5, or 585.9
Disorders resulting from impaired renal
function
588
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attending the follow up social worker session, we con-
tact family members via telephone to obtain their con-
sent for participating in the study using a prepared
telephone script and oral consent process. Some partici-
pants bring additional family members, friends, or other
non-relatives to visits beyond those consented. We
therefore also obtain written consent from family mem-
bers or friends attending social worker meetings.
Randomization
Using blind and secure allocation by computer, we ran-
domly assign participants to one of three intervention
arms: 1) control group ("Usual Care”); 2) video and
booklet intervention only ("TALK Program”); and 3)
video, booklet plus social worker intervention ("TALK
Plus Program”). Randomization is blocked by recruit-
ment site to ensure equal allocation within each site.
Usual Care Group
Participants randomly assigned to receive Usual Care
proceed with their usual clinical care with their nephrol-
ogists as already routinely implemented by their physi-
cians. Since all patient participants have stage 4 CKD at
the time of recruitment, many have already had some
discussions of options for renal replacement therapy
with their physicians (including LKT). Many practices
from which patient participants are recruited routinely
refer patients to “pre-dialysis education” group sessions
led by dialysis social workers and nurses to discuss the
process of preparation for dialysis and transplantation.
Intervention Groups
Patient participants randomly assigned to receive the
TALK Program receive the culturally sensitive educa-
tional booklet and video at the time of enrollment. We
provide participants the option of reviewing these materi-
als on their own or with study staff in their homes or at a
public location of their choice. Study staff members also
encourage patient participants to share the materials with
their family members or friends. Participants randomly
assigned to receive the TALK-Plus Program receive the
culturally sensitive educational booklet and video at the
time of enrollment in a similar fashion with a similar
approach to the TALK Plus assignment. In addition, par-
ticipants in this group are invited to participate in an
initial 60-minute counseling session with a licensed social
worker experienced in working with patients and families
undergoing evaluation for transplant surgery followed by
a second 60-minute session with the social worker and
their families, if patient participants desire. All partici-
pant meetings are audio-recorded and later transcribed
verbatim, excluding names of participants for analysis of
participant meeting content.
Data collection, follow-up and outcomes
Measures Assessed Through Structured Interviews All
patient participants enrolled in the study are assessed
using structured interviews administered by telephone at
baseline, 1 month, 3 months, and 6 months following
recruitment and enrollment in the study.
The primary outcome is change in participants’ con-
sideration of LKT over time. This outcome is measured
as participants’ movement through 12 possible beha-
vioral ‘stages’ reflecting their completion of key steps
toward considering LKT, including (1) preparation for
and/or execution of patient-family discussions about
LKT; (2) preparation for and/or execution of patient-
physician discussions about LKT; (3) preparation for
and/or completion of evaluation for LKT; (4) comple-
tion of the LKT recipient evaluation, and (5) identifica-
tion of a potential live kidney donor. To assess these
behaviors, we ask participants a series of questions to
which they can answer ‘yes’ or ‘no’ (e.g. “Have you
already completed the testing process to get a kidney
transplant?”). We categorize participants into one of the
12 stages based on their answers. Once we have categor-
ized the participants, we also assess potential barriers to
consideration of LKT, including the barriers to discus-
sions with family and providers about LKT (e.g. diffi-
culty discussing LKT with physician, competing
priorities, uncertainty about desire for LKT). (Figure 1)
Other measures include assessment of participants’ (1)
access to and sources of information about LKT; (2)
barriers to obtaining information on LKT; (3) prior dis-
cussions with health care providers about LKT; (4) per-
ceived satisfaction and patient-centeredness of their
relationship with their nephrologist; (5) preferred role in
decision-making about LKT; (6) beliefs about the bene-
fits of LKT; (7) knowledge and interest regarding LKT;
(8) concerns about the risks of LKT to themselves and
to donors; (9) family structure and relationships; (10)
depression and social support; (11) religiosity/spiritual-
ity; (12) financial stress, (13) health literacy, and (14)
sociodemographic characteristics. (Table 3) For patient
participants assigned to the TALK and TALK-Plus
groups, we also assess their perceptions of the helpful-
ness of the video and booklet.
Patient participants’ family members are assessed once
after patient participants’ 1-month assessments and once
after patient participants’ 3-month assessment via struc-
tured interviews administered via telephone. Assessments
include family members’: (1) access to and sources of
information regarding LKT (including whether family
members have reviewed intervention materials with
patient participants); (2) knowledge about LKT; (3) pre-
sence and quality of family discussions about LKT.
Social Worker Assessments
For participants randomized to receive social worker
meetings (TALK Plus Program) social workers docu-
ment potential barriers to LKT elucidated by patients
and families, and assess immediate outcomes of patient/
family discussions, including: (1) whether patients and
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Figure 1 Schematic describing determination of key behaviors representing consideration of LKT in the TALK study. *Participants
assumed to have discussed LKT with physicians if they had begun their clinical evaluation for LKT; Participants also assumed to have discussed
LKT with their families if they identified a donor.
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families arrived at consensus regarding mutual patient/
family solutions, (2) presence (or lack thereof) of plans
agreed upon by patients and families to discuss LKT
with patients’ physicians, and (3) presence (or lack
thereof) of plans agreed upon by patients and families to
pursue evaluation for LKT.
Statistical Considerations
Data Analysis
Randomly assigned intervention group (i.e. Usual Care,
Talk Study, TALK Plus) will be the main independent
variable for intent-to-treat analysis [23]. The co-primary
outcomes are change in consideration of LKT at 3 and
Table 3 Schedule of patient and family participant assessments in the TALK study
PATIENT FAMILY
Measure Baseline 1
Month
3
Month
6
Month
Baseline 3
Month
Exposure to information about Kidney Disease Treatment
Dialysis Information X X X X X X
Kidney Transplant Information X X X X X X
Live Donor Kidney Transplant Information X X X X X X
Discussions with Health Care Providers about Kidney Disease Treatment
Prior Discussions with Social Worker(s) X X
Occurrence of Physician Discussions-Primary Care, Nephrologists X
Perception of Centeredness in Patient-Physician Discussions [34] X X X
Satisfaction with Patient-Physician Discussions X
Physician Recommendations regarding LKT X
Belief & Knowledge about Treatment for Kidney Failure, Interest in LKT
Beliefs About Treatment for Kidney Failure X X X X
Knowledge of LKT X X X X X X
Interest in LKT X X X X
Consideration of LKT (stage placement) X X X X
Pursuit of LKT, Barriers to Completing Behavior Stages
Quality of Family Discussion X X X X X X
Information on Donor X X X X
Barriers to Patient-Family Discussion X X X X
Barriers to Patient-Physician Discussion X X X X
Barriers to Starting Evaluation X X X X
Barriers to Completing Evaluation X X X X
Mediators and Correlates of Pursuit of LKT
Trust in Medical Care [35-37] X
Patient Activation Measure-Short Form [38] X X X X
Decision Self-Efficacy [39] X X X X
Family Structure Inventory X
Family Assessment Device (General, Communication, and Problem Solving Scales)[40,41] X X X X X
Depressed Mood-Prime MD/PHQ [42] X X X
Medical Outcomes Study (MOS) Social Support Scale [43] X X X
Spirituality & Religion [44] X
Trait Hope Scale [45] X X X X
Personal Financial Well-being Scale [46] X
Sociodemographic Information X X
Assessment of Booklet and Video
Assessment of Booklet and Video X X X X X
Health Literacy
Rapid Estimate of Adult Literacy in Medicine (REALM) [47] X
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6 months. To evaluate the effectiveness of the interven-
tion on outcomes, we will utilize generalized estimating
equations, which account for the longitudinal nature of
the trial and incorporate baseline, 3 and 6 months mea-
surements as well as study site characteristics and other
baseline characteristics found not to be balanced by ran-
domization. Secondary analyses will include exploratory
analyses stratifying participants according to ethnicity/
race to assess differences intervention effectiveness
among African Americans and non-African Americans.
We will also perform exploratory analyses among per-
sons within subgroups defined post-randomization–for
example, analyses among persons with greater versus
less knowledge of LKT at baseline. We will conduct pri-
mary analyses under the assumption that data is missing
at random, however, we will also perform sensitivity
analyses based on other scenarios (i.e. patterns of miss-
ing data) to evaluate the robustness of our assumptions.
Sample Size and Power
Our main analysis will assess the proportion of partici-
pants in each randomized group that has moved one
additional step ‘forward’ in consideration of LKT over
study follow up. We are not aware of other studies
assessing this outcome among patients and families who
have not yet initiated dialysis therapies. We conserva-
tively assume that approximately 30% of our partici-
pants, who have not yet initiated dialysis, will consider
LKT as a treatment option under usual care at follow
up [5,24,25]. A recently performed randomized con-
trolled trial indicated that engagement of family in dis-
cussions about LKT improved rates of donor
evaluations up to 2-fold [26]. Based on this data, we
assume that our educational interventions (video and
booklet) could improve consideration by approximately
2-fold and that the behavioral intervention (social
worker) would additionally improve the effectiveness of
the intervention by 10% (i.e. 30%, 60%, 70% considera-
tion of LKT at follow up in the usual care, Talk, and
Talk Plus groups, respectively). Under these assump-
tions, for two-sided 0.05 level test of the null hypothesis,
recruitment of 40 participants per group should provide
approximately 95% power to detect statistically signifi-
cant differences in consideration of LKT.
Discussion
Despite the success of LKT as a treatment strategy for
ESRD, improvements in utilization have been largely
stagnant in recent years, and ethnic/racial disparities in
utilization of LKT persist [2,27]. Although efforts to
improve early consideration of LKT are advocated [28],
effective strategies for engaging ethnic/racial minority
and non-minority patients and their families in early,
shared and informed consideration of LKT have not
been studied. The TALK study has rigorously developed
and is currently testing the effectiveness of novel strate-
gies to improve ethnic/racial minority and non-minority
patients’ and families’ early, shared and informed con-
sideration of LKT as treatment option.
The TALK study represents one of the first efforts to
explicitly design culturally sensitive interventions to
improve African American’ and non-African Americans’
early consideration of LKT. Prior studies of educational
interventions among patients with progressive chronic
kidney disease have not assessed the effect of early edu-
cation on patients’ or their families’ consideration of
LKT and have not examined whether interventions nar-
row ethnic/race differences in consideration of treat-
ments among United States patients [29,30]. A recent
study among patients who were already treated on dialy-
sis demonstrated home visits performed by health pro-
fessionals to engage patients and families in shared and
informed decision-making about LKT were effective in
improving minority and non-minorities’ consideration of
LKT [26]. However, this study did not address the effec-
tiveness of earlier educational interventions to improve
patients’ and their families’ consideration of LKT. Inter-
ventions supporting patients’ and families’ earlier con-
sideration of LKT could provide patients and families
needed time to discuss LKT and initiate steps toward
pursuit before patients and families experience com-
monly reported psychosocial and physical stress asso-
ciated with dialysis initiation [31-33].
Our efforts to identify both shared and differing con-
cerns about pursuing LKT among minority and non-
minority patients and families represent a novel strategy
for developing culturally sensitive interventions to
improve consideration of LKT and could enhance inter-
ventions’ effectiveness. If effective, interventions could
serve as a model for future programs seeking to provide
resources to support ethnic/racial minority and non-
minority patients’ and families’ early and informed deci-
sions about LKT. Our collection of information on fac-
tors contributing to interventions’ success (e.g. the
patient-physician relationship and family members’ per-
spectives on the process of considering LKT in discus-
sions) will provide additional valuable insight into the
mechanisms through which interventions may act as
well as ways in which interventions might be further tai-
lored to optimize their effectiveness.
In summary, the TALK study has rigorously developed
and is currently testing the effectiveness of culturally
sensitive educational and behavioral interventions to
improve patients’ and families’ early and informed con-
sideration of LKT. Results from TALK will provide
needed evidence regarding ways to enhance considera-
tion of this optimal treatment strategy among African
American and non-African American patients and
families.
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